Mirae Asset Global Etfs Holdings Ltd. Axsome Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,897 shares of AXSM stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,897Holding current value
$1.64 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
288Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$424 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$343 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$302 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$216 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$170 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.93B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...